Open AccessEfficacy of oral zinc therapy in epidermodysplasia verruciformis with squamous cell carcinoma
Author(s) -
Sudhanshu Sharma,
Krishna Deb Barman,
Rashmi Sarkar,
Mukesh Manjhi,
Vijay Kumar Garg
Publication year - 2014
Publication title -
indian dermatology online journal
Language(s) - English
Resource type - Journals
eISSN - 2249-5673
pISSN - 2229-5178
DOI - 10.4103/2229-5178.126034
Subject(s) - epidermodysplasia verruciformis , medicine , basal cell , dermatology , human papillomavirus , zinc , zinc compounds , cancer research , oncology , materials science , metallurgy
Epidermodysplasia verruciformis (EV) is a rare, inherited disorder that predisposes patients to widespread human papillomavirus (HPV) infection and cutaneous squamous cell carcinomas. There is still no definitive therapeutic modality for EV. A 24 year old male patient with EV was treated with oral zinc sulphate, one of the cheapest and safe immuno-modulator available as therapeutic agent with satisfactory result.